Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1725 (LINC01725) is a human gene encoding a long intergenic non-coding RNA (lincRNA), a subclass of long non-coding RNAs that are transcribed from regions of the genome more than 200 nucleotides in length and do not overlap protein-coding genes. LincRNAs such as LINC01725 are thought to participate in gene regulation, chromatin remodeling, and epigenetic modification, often exhibiting high tissue specificity in their expression. Although many lincRNAs have been implicated in development and disease, the specific biological function of LINC01725 is not well characterized, but it has been associated with altered expression in liver diseases such as non-alcoholic fatty liver disease (NAFLD) and cirrhosis[1][2][3][5]. No drugs are known to target LINC01725, and it is not currently regarded as a validated therapeutic target.
Not applicable, as no drugs are known to target LINC01725.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1725 (LINC01725).